Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot Study
Condition: Metabolic Associated Fatty Liver Disease Intervention: Drug: dapagliflozin (Forxiga) Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 24, 2023 Category: Research Source Type: clinical trials
Empagliflozin and Dapagliflozin in Patients Hospitalized for Acute Decompensated Heart Failure
Condition: Acute Decompensated Heart Failure Interventions: Drug: Empagliflozin 10 MG; Drug: Dapagliflozin 10 MG; Drug: Placebo Sponsors: Medical University of Warsaw; Medical University of Vienna; Medical University of Graz; University Clinical Center of the Medical University of Warsaw; Jerzy Popiełuszko Bielański Hospital in Warsaw; Regional Polyclinical Hospital in Kielce; University Clini cal Hospital Military Medical Academy, Central Veterans Hospital in Łódź; Medical University of Gdańsk; Autonomous Public Specialist Western John Paul II Hos...
Source: ClinicalTrials.gov - March 20, 2023 Category: Research Source Type: clinical trials
